Business Wire

MA-DESKTOP-METAL

19.4.2022 14:32:12 CEST | Business Wire | Press release

Share
Desktop Metal Introduces the All-New S-Max® Flex, a Robotic Additive Manufacturing 2.0 System that Makes Sand 3D Printing Affordable to Foundries Worldwide

Desktop Metal (NYSE: DM) today announced the launch of the ExOne S-Max® Flex, a scalable, large-format binder jetting system that 3D prints sand tooling, which foundries use to quickly cast complex metal designs for the aerospace, automotive, and energy industries, among others.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220419005064/en/

ExOne, which was acquired by Desktop Metal in late 2021, is the leading digital sand printing solution provider for foundries. The new S-Max Flex combines ExOne’s sand printing expertise in process and materials with proprietary Desktop Metal SPJ technology in an affordable architecture to deliver new value to foundries that have long wanted an S-Max but found the premium price out of reach.

The S-Max Flex will debut at CastExpo 2022, North America’s largest metalcasting trade show, from April 23-26 in Columbus, Ohio. A video highlighting the benefits of the S-Max Flex for early customers, including Alpha Foundry of Wright City, Mo., and D.W. Clark in Taunton, Mass., was released today at www.exone.com/flexvideo .

“To achieve our vision of Additive Manufacturing 2.0, we need to make production 3D printing practical in terms of speed, cost, and material availability for a broad range of applications,” said Ric Fulop, Co-Founder and CEO of Desktop Metal. “We designed the all-new S-Max Flex from the ground up leveraging SPJ technology with the idea of making premium sand 3D printing accessible to every foundry, so that more companies can take advantage of the benefits of AM 2.0, such as distributed, local production, and remain competitive for the long term.”

The S-Max Flex comes to market at a time of strong demand for castings, along with challenges finding labor. After years of contraction, the U.S. metalcasting industry is experiencing growth as a result of supply chain changes related to the COVID-19 pandemic. A recent survey released by the American Foundry Society shows that 90 percent of responding North American foundries have a positive business outlook and anticipate making capital investments in the next 12 months, including of 3D printers.

Additional early buyers of the new S-Max Flex include Founders Service & Manufacturing Co. Inc. of Deerfield, Ohio, and HTCI Co. of New Carlisle, Ohio.

Details of the S-Max Flex
The S-Max Flex pairs an affordable industrial robot with an all-new end effector printhead design that deposits binder into a 1900 x 1000 x 1000 mm (74 x 39 x 39 in) telescoping build box that grows as the parts are built layer by layer. Additional build box sizes are available up to 4700 x 1000 x 1000 mm (185 x 39 x 39 in), with taller versions available up to 1000 x 2500 x 2400 mm (39 x 98 x 94 in).

Desktop Metal’s high throughput SPJ technology delivers a build rate up to 115 l/h, which offers foundries quick and reliable production to operate more efficiently in times of ongoing labor shortages, as well as a faster return on investment. The S-Max Flex joins the premium S-Max® and S-Max® Pro solutions that are used in foundries worldwide.

The all-new S-Max Flex prints standard silica sand with furan binders and delivers final parts with dimensional accuracy of +/- 0.5 mm. The system comes with several accessories and safety features that are configurable to fit a variety of spaces.

Industries beyond metalcasting are also set to take advantage of the S-Max Flex’s large form factor and ability to binder jet a variety of powders. Infiltrated sand tooling for plastic thermoforming, composite layup, and sacrificial tooling applications are printed today on S-Max machines, along with infiltrated sand consumer products, such as those offered by Sandhelden and Deeptime . Desktop Metal’s Forust brand, which upcycles byproducts of the wood waste stream into consumer designs, will also leverage the new system to print large form factor wood parts at scale cost-effectively. Additional projects are underway printing reclaimed concrete and other materials.

Binder Jetting - the Fastest AM Method for Mass Production
Binder jet 3D printing is widely regarded as the fastest additive manufacturing method for the mass production of functional precision parts. Sand binder jet 3D printing has been used in foundries for more than two decades to create metalcasting tooling cost-effectively and with low turnaround times.

In the binder jetting process, an industrial printhead selectively deposits a binder into a bed of sand particles creating a solid part one thin layer at a time, similar to printing on sheets of paper. 3D printing straight from CAD files enables foundries to eliminate the months-long lead times and high costs of traditional patterns and coreboxes created from wood or metal. The design freedom of additive manufacturing also allows designers to innovate the parts made with the reliable casting process – creating complex, consolidated geometries that enable lightweighting and optimized part performance not possible with traditional processes.

For more information on the ExOne S-Max Flex system, visit www.exone.com .

About Desktop Metal
Desktop Metal, Inc., based in Burlington, Massachusetts, is accelerating the transformation of manufacturing with an expansive portfolio of 3D printing solutions, from rapid prototyping to mass production. Founded in 2015 by leaders in advanced manufacturing, metallurgy, and robotics, the company is addressing the unmet challenges of speed, cost, and quality to make additive manufacturing an essential tool for engineers and manufacturers around the world. Desktop Metal was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum, named to MIT Technology Review’s list of 50 Smartest Companies, and the 2021 winner of Fast Company’s Innovation by Design Award in materials and Fast Company’s Next Big Things in Tech Award for sustainability. For more information, visit www.desktopmetal.com .

Forward-looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to, the risks and uncertainties set forth in Desktop Metal, Inc.'s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Link:

ClickThru

Social Media:

https://www.facebook.com/DesktopMetal/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye